| 【Company Research】Jiangsu Hengli (601100 CH) – 2Q23 earnings +24%; Gross margin below expectations but likely rebounds |
| 【Company Research】SenseTime (20 HK) – Focus on Generative AI business development |
| 【Company Research】Wingtech (600745 CH) – Strong 2Q23 results on ODM business turning profitable |
| 【Company Research】Innolight (300308 CH) – Investors focusing on 800G transceivers ramp-up after 1H23 results |
| 【Company Research】CTGDF (601888 CH) – 2Q in line with profit alert; subtle recovery ahead |
| 【Company Research】Henlius Biotech (2696 HK) – Profit turnaround in 1H23 |
| 【Company Research】Tigermed (300347 CH) – Healthy growth amid challenging environment |
| 【Company Research】Yongda Automobiles (3669 HK) – New-car GPM may bottom out in 2H23E |
| 【Company Research】AAC Tech (2018 HK) – 1H23 weakness in-line; Maintain HOLD on fair valuation |
| 【Company Research】PA Good Doctor (1833 HK) – Business restructuring closes to the end |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
